From Brain to Blood: Uncovering Potential Therapeutical Targets and Biomarkers for Huntington’s Disease Using an Integrative RNA-Seq Analytical Platform (BDASeq<sup>®</sup>)
Background: Huntington’s Disease (HD) remains without disease-modifying treatments, with existing therapies primarily targeting chorea symptoms and offering limited benefits. This study aims to identify druggable genes and potential biomarkers for HD, focusing on using RNA-Seq analysis to uncover mo...
Saved in:
| Main Authors: | João Rafael Dias Pinto, Benedito Faustinoni Neto, Luciana Munhoz, Irina Kerkis, Rodrigo Pinheiro Araldi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/13/976 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase II trial of intravenous human dental pulp stem cell therapy for Huntington’s disease: a randomized, double-blind, placebo-controlled study
by: Joyce Macedo Sanches Fernandes, et al.
Published: (2025-08-01) -
Recognizing familial Huntington's disease in an Asian cohort: Insights from the Philippines
by: Jao Jarro B. Garcia, et al.
Published: (2025-03-01) -
Non-choreic movement disorders as initial manifestations of Huntington's disease Distúrbios do movimento não-coreicos como manifestação inicial da doença de Huntington
by: Nilson Becker, et al.
Published: (2007-06-01) -
Juvenile Huntington disease in Argentina
by: Emilia Mabel Gatto, et al.
Published: (2015-01-01) -
Juvenile Huntington's disease confirmed by genetic examination in twins Doença de Huntington juvenil confirmada por exame genético em gêmeas
by: GILBERTO LEVY, et al.
Published: (1999-09-01)